Showing results (131-140 of 189) with videos related to

Sort By:
Pageof 19
Autoimmunity Reviews|October 29, 2011
Efficacy of rituximab in 164 patients with biopsy-proven lupus nephritis: pooled data from European cohortsCándido Díaz-Lagares, Sara Croca, Shirish Sangle, et al.
Rheumatology (Oxford, England)|January 19, 2010
The BILAG multi-centre open randomized controlled trial comparing ciclosporin vs azathioprine in patients with severe SLEBridget Griffiths, Paul Emery, Vicky Ryan, et al.
Arthritis Care & Research|March 23, 2011
Decreased live births in women with systemic lupus erythematosusEvelyne Vinet, Ann E Clarke, Caroline Gordon, et al.
International Journal of Molecular Sciences|July 24, 2021
Biomarkers Associated with Organ-Specific Involvement in Juvenile Systemic Lupus ErythematosusJames Greenan-Barrett, Georgia Doolan, Devina Shah, et al.
The Journal of Rheumatology|December 4, 2009
Risk factors for clinical coronary heart disease in systemic lupus erythematosus: the lupus and atherosclerosis evaluation of risk (LASER) studySahena Haque, Caroline Gordon, David Isenberg, et al.
The Journal of Rheumatology|January 17, 2018
Smoking Is the Most Significant Modifiable Lung Cancer Risk Factor in Systemic Lupus ErythematosusSasha Bernatsky, Rosalind Ramsey-Goldman, Michelle Petri, et al.
Rheumatology (Oxford, England)|May 3, 2019
Recommendations for acquisition and interpretation of MRI of the spine and sacroiliac joints in the diagnosis of axial spondyloarthritis in the UKTimothy J P Bray, Alexis Jones, Alexander N Bennett, et al.
Clinical Medicine (London, England)|May 17, 2020
Experience from the first UK inter-regional specialist multidisciplinary meeting in the diagnosis and management of IgG4-related diseaseGeorge Goodchild, Rory Jr Peters, Tamsin N Cargill, et al.
Scientific Reports|October 31, 2019
Differential Treatments Based on Drug-induced Gene Expression Signatures and Longitudinal Systemic Lupus Erythematosus StratificationDaniel Toro-Domínguez, Raúl Lopez-Domínguez, Adrián García Moreno, et al.
Elife|November 21, 2024
ACK1 and BRK non-receptor tyrosine kinase deficiencies are associated with familial systemic lupus and involved in efferocytosisStephanie Guillet, Tomi Lazarov, Natasha Jordan, et al.
Pageof 19